SI9300158A - Nov postopek za pripravo paroksetina in v njem uporabljeni doloceni novi intermediati - Google Patents

Nov postopek za pripravo paroksetina in v njem uporabljeni doloceni novi intermediati Download PDF

Info

Publication number
SI9300158A
SI9300158A SI9300158A SI9300158A SI9300158A SI 9300158 A SI9300158 A SI 9300158A SI 9300158 A SI9300158 A SI 9300158A SI 9300158 A SI9300158 A SI 9300158A SI 9300158 A SI9300158 A SI 9300158A
Authority
SI
Slovenia
Prior art keywords
formula
compound
isomer
paroxetine
process according
Prior art date
Application number
SI9300158A
Other languages
English (en)
Slovenian (sl)
Inventor
Alan David Courzons
Lawson William Powell
Alan Martin Keay
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SI9300158A publication Critical patent/SI9300158A/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SI9300158A 1992-05-06 1993-03-31 Nov postopek za pripravo paroksetina in v njem uporabljeni doloceni novi intermediati SI9300158A (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209687A GB9209687D0 (en) 1992-05-06 1992-05-06 Novel process

Publications (1)

Publication Number Publication Date
SI9300158A true SI9300158A (sl) 1993-12-31

Family

ID=10715029

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300158A SI9300158A (sl) 1992-05-06 1993-03-31 Nov postopek za pripravo paroksetina in v njem uporabljeni doloceni novi intermediati

Country Status (33)

Country Link
US (1) US20010018205A1 (fi)
EP (1) EP0639180B1 (fi)
JP (1) JPH07507277A (fi)
KR (1) KR100287082B1 (fi)
CN (2) CN1059898C (fi)
AP (1) AP404A (fi)
AT (1) ATE194329T1 (fi)
AU (1) AU673166B2 (fi)
BR (1) BR9306326A (fi)
CA (1) CA2135169A1 (fi)
CZ (1) CZ283702B6 (fi)
DE (1) DE69328969T2 (fi)
DK (1) DK0639180T3 (fi)
ES (1) ES2147196T3 (fi)
FI (1) FI106855B (fi)
GB (1) GB9209687D0 (fi)
GR (1) GR3034034T3 (fi)
HK (1) HK1012374A1 (fi)
HU (1) HU215411B (fi)
IL (1) IL105162A (fi)
MA (1) MA22848A1 (fi)
MX (1) MX9301754A (fi)
MY (1) MY110188A (fi)
NO (1) NO944215D0 (fi)
NZ (1) NZ251404A (fi)
PL (1) PL172067B1 (fi)
PT (1) PT639180E (fi)
RU (1) RU2108393C1 (fi)
SI (1) SI9300158A (fi)
SK (1) SK281767B6 (fi)
TW (1) TW258732B (fi)
WO (1) WO1993022284A1 (fi)
ZA (1) ZA932212B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
EP0937152A2 (en) * 1996-07-15 1999-08-25 Smithkline Beecham Plc Screening for and use of an esterase for a stereospecific resolution
GB9618967D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Pharmaceuticals
AU3108097A (en) 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
IT1308629B1 (it) * 1999-02-23 2002-01-09 Recordati Chem Pharm Processo per la produzione di paroxetina.
ES2161167B1 (es) * 1999-09-24 2002-07-01 Vita Invest Sa Procedimiento de hidrolisis enzimatica de esteres del acido (3sr,4rs)-4-(4-fluorofenil)-6-oxopiperidin-3-carboxilico con biocatalizadores de lipasas o esterasas inmovilizadas.
CZ20023694A3 (cs) 2000-05-12 2003-05-14 Synthon B. V. Tosylátové soli 4-(p-fluorfenyl)-piperidin-3-methanolů
WO2009005647A2 (en) * 2007-06-27 2009-01-08 Bioverdant, Inc. Compounds and process to prepare chiral intermediates for synthesis of paroxetine
CN104892491B (zh) * 2015-05-06 2017-05-17 浙江海森药业有限公司 一种合成帕罗西汀手性中间体的方法
KR102168129B1 (ko) 2018-11-28 2020-10-20 장영선 넝쿨작물용 줄기 유인용 집게

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3010104A1 (de) * 1980-03-15 1981-10-01 Basf Ag, 6700 Ludwigshafen Aminoazoverbindungen
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine

Also Published As

Publication number Publication date
BR9306326A (pt) 1998-06-30
CN1096054A (zh) 1994-12-07
IL105162A (en) 1999-01-26
FI106855B (fi) 2001-04-30
AU3899993A (en) 1993-11-29
DE69328969D1 (de) 2000-08-10
ZA932212B (en) 1994-09-28
JPH07507277A (ja) 1995-08-10
HK1012374A1 (en) 1999-07-30
FI945209A0 (fi) 1994-11-04
SK281767B6 (sk) 2001-07-10
CN1059898C (zh) 2000-12-27
AP9300501A0 (en) 1993-04-30
WO1993022284A1 (en) 1993-11-11
EP0639180A1 (en) 1995-02-22
GB9209687D0 (en) 1992-06-17
RU2108393C1 (ru) 1998-04-10
KR100287082B1 (ko) 2002-08-14
FI945209A (fi) 1994-11-04
AU673166B2 (en) 1996-10-31
CA2135169A1 (en) 1993-11-11
DK0639180T3 (da) 2000-11-06
IL105162A0 (en) 1993-07-08
SK131594A3 (en) 1995-06-07
CN1291653A (zh) 2001-04-18
NO944215L (no) 1994-11-04
EP0639180B1 (en) 2000-07-05
MX9301754A (es) 1993-11-01
MA22848A1 (fr) 1993-10-01
GR3034034T3 (en) 2000-11-30
TW258732B (fi) 1995-10-01
RU94046012A (ru) 1996-09-20
PT639180E (pt) 2000-10-31
AP404A (en) 1995-09-02
DE69328969T2 (de) 2000-12-07
MY110188A (en) 1998-02-28
NO944215D0 (no) 1994-11-04
HUT69945A (en) 1995-09-28
NZ251404A (en) 1996-10-28
HU215411B (hu) 2000-03-28
ES2147196T3 (es) 2000-09-01
CZ271294A3 (en) 1995-07-12
ATE194329T1 (de) 2000-07-15
US20010018205A1 (en) 2001-08-30
KR950701326A (ko) 1995-03-23
CZ283702B6 (cs) 1998-06-17
PL172067B1 (pl) 1997-07-31

Similar Documents

Publication Publication Date Title
US5258517A (en) Method of preparing optically pure precursors of paroxetine
SI9300158A (sl) Nov postopek za pripravo paroksetina in v njem uporabljeni doloceni novi intermediati
CA2272373A1 (en) The preparation of enantiomerically-enriched threo-methylphenidate
JPH01254661A (ja) R―およびs―アムロジピンの製造
US6716985B2 (en) Process for making paroxetine
RU2167868C2 (ru) Способ получения норбензоморфана
SK143793A3 (en) The enzymatic process for the stereoselective preparation of a heterobicyclic alcohol enantiomer
US6469173B1 (en) Alkyl esters of 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionic acid of use as intermediates
US6184005B1 (en) Enzymatic resolvation for obtaining a (−)-3,4-trans-diarylchroman
IL95213A (en) Quinine salt of R3-) 3-carboxybenzyl (-6-) 5-fluoro-2-benzothiazolyl (methoxy-R4-chromanol and method for its preparation
CA2116108A1 (en) Chiral gultarate esters, their resolution and derived glutarimide compounds
WO2002032870A1 (en) Process of the preparation of 3-substituted-4-aryl piperidine compounds
Lewin et al. Jan-Fel l937 A Practical Synthesis of (+)-Cocaine 19
AU1563002A (en) Novel process